Clinical Trial

Evaluate the Efficacy and Safety of DWP712 With Moderate to Severe Glabellar Lines

Name: Evaluate the Efficacy and Safety of DWP712 With Moderate to Severe Glabellar Lines — clinical trial record (NCT07013279)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Record status

This record was last updated June 10, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.

Summary

To evaluate the efficacy and safety of DWP712 Inj. in Subjects with Moderate to Severe Glabellar Lines

Trial Details

NCT Number	NCT07013279
Lead Sponsor	Daewoong Pharmaceutical Co. LTD.
Conditions	Glabellar Lines
Enrollment	324 participants
Start Date	2025-07-15
Primary Completion	2025-12-31 (estimated)
Study Completion	2026-03-31 (estimated)
Updated on ClinicalTrials.gov	2025-06-10